Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms, and Antiplatelet Therapy and Cardiovascular Diseases.
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team
Treating cancer-associated venous thromboembolism: A practical approach
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study
Derivation of an Outcome-Driven Threshold for Aortic Pulse Wave Velocity: An Individual-Participant Meta-Analysis
Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience
All Staphylococcus aureus bacteraemia-inducing strains can cause infective endocarditis: Results of GWAS and experimental animal studies
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis
Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
<i>Staphylococcus aureus</i> and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in Immunothrombosis
Neutrophils Protect Against <i>Staphylococcus aureus</i> Endocarditis Progression Independent of Extracellular Trap Release
Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19
Abelacimab for Prevention of Venous Thromboembolism
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review
Rationale for azithromycin in COVID-19: an overview of existing evidence
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study
Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
Relative and Absolute Risk to Guide the Management of Pulse Pressure, an Age-Related Cardiovascular Risk Factor
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease
Coagulation: At the heart of infective endocarditis